Crewe Advisors LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

Back to all holdings Add to watchlist

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Crewe Advisors LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$325,573
-18.8%
59,7380.0%0.06%0.0%
Q2 2023$400,842
-24.0%
59,7380.0%0.06%
-27.3%
Q1 2023$527,487
+15.6%
59,7380.0%0.08%
+6.9%
Q4 2022$456,398
+7.1%
59,738
-0.2%
0.07%
-6.5%
Q3 2022$426,000
-12.0%
59,8510.0%0.08%
-28.0%
Q2 2022$484,000
-41.1%
59,851
+1.0%
0.11%
-33.1%
Q1 2022$822,000
-50.5%
59,238
+0.2%
0.16%
-52.5%
Q4 2021$1,659,000
-17.5%
59,1380.0%0.34%
-29.1%
Q3 2021$2,010,000
-16.8%
59,1380.0%0.48%
-20.7%
Q2 2021$2,416,000
+1.5%
59,1380.0%0.60%
+1.4%
Q1 2021$2,381,000
-31.9%
59,1380.0%0.59%
-57.8%
Q4 2020$3,497,000
-5.4%
59,138
-22.2%
1.40%
-19.3%
Q3 2020$3,696,000
-6.2%
76,008
-6.6%
1.73%
-9.9%
Q2 2020$3,939,000
+52.4%
81,418
-12.5%
1.92%
+24.8%
Q1 2020$2,584,000–93,000–1.54%–
 Download
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders